top
Search terms
Results 1 - 10 of 11 - ordered by :
Pages: 1 2
Ehjournal

Dabigatran vs. placebo in patients with acute coronary syndromes on dual antiplatelet therapy: a randomized, double-blind, phase II trial Methods and results In this double-blind, ...

European Heart Journal, Oldgren, Jonas, Budaj, Andrzej, Granger, Christopher B., Khder, Yasser, Roberts, Juliet, Siegbahn, Agneta, Tijssen, Jan G.P., Van de Werf, Frans, Wallentin, Lars

Date : 01/11/2011
Ehjournal

In the placebo arm, patients who more recently stopped P2Y12 inhibitor therapy had a greater number of risk factors but still had a higher risk of MACE after multivariable adjustment [30 days, hazard ...

European Heart Journal, Bonaca, Marc P., Bhatt, Deepak L., Steg, P. Gabriel, Storey, Robert F., Cohen, Marc, Im, Kyungah, Oude Ophuis, Ton, Budaj, Andrej, Goto, Shinya, López-Sendón, José, ...

Date : 07/04/2016 Item size : 264052 bytes
Ehjournal

Dabigatran vs. placebo in patients with acute coronary syndromes on dual antiplatelet therapy: a randomized, double-blind, phase II trial Methods and results In this double-blind, ...

European Heart Journal, Oldgren, Jonas, Budaj, Andrzej, Granger, Christopher B., Khder, Yasser, Roberts, Juliet, Siegbahn, Agneta, Tijssen, Jan G.P., Van de Werf, Frans, Wallentin, Lars

Date : 01/11/2011
Ehjournal

Current management of ACS consists of acute administration of antiplatelet and anticoagulant agents, revascularization procedures [plus reperfusion therapy with lytic agents or percutaneous coronary ...

European Heart Journal, Van de Werf, Frans

Date : 01/11/2010
Ehjournal

2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTSThe Task Force for dual antiplatelet therapy in coronary artery disease of the ...

European Heart Journal, Valgimigli, Marco, Bueno, Héctor, Byrne, Robert A, Collet, Jean-Philippe, Costa, Francesco, Jeppsson, Anders, Jüni, Peter, Kastrati, Adnan, Kolh, Philippe, Mauri, Laura, ...

Date : 14/01/2018 Item size : 346469 bytes
Ehjournal

2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTSThe Task Force for dual antiplatelet therapy in coronary artery disease of the ...

European Heart Journal, Valgimigli, Marco, Bueno, Héctor, Byrne, Robert A, Collet, Jean-Philippe, Costa, Francesco, Jeppsson, Anders, Jüni, Peter, Kastrati, Adnan, Kolh, Philippe, Mauri, Laura, ...

Date : 14/01/2018
Ehjournal

Clopidogrel instead of prasugrel or ticagrelor after 1 month in stabilized ACS patients: back to square one for DAPT? Following an acute coronary syndrome (ACS), patients remain at risk for new ...

European Heart Journal, Sinnaeve, Peter R., Van de Werf, Frans

Date : 01/11/2017 Item size : 117056 bytes
Ehjournal

Clopidogrel instead of prasugrel or ticagrelor after 1 month in stabilized ACS patients: back to square one for DAPT? Following an acute coronary syndrome (ACS), patients remain at risk for new ...

European Heart Journal, Sinnaeve, Peter R., Van de Werf, Frans

Date : 01/11/2017 Item size : 137574 bytes
Ehjournal

In the placebo arm, patients who more recently stopped P2Y12 inhibitor therapy had a greater number of risk factors but still had a higher risk of MACE after multivariable adjustment [30 days, hazard ...

European Heart Journal, Bonaca, Marc P., Bhatt, Deepak L., Steg, P. Gabriel, Storey, Robert F., Cohen, Marc, Im, Kyungah, Oude Ophuis, Ton, Budaj, Andrej, Goto, Shinya, López-Sendón, José, ...

Date : 07/04/2016 Item size : 305720 bytes
Ehjournal

The recommended duration of 1year of dual antiplatelet therapy (DAPT) after an ACS is arbitrarily based on the treatment duration in the Clopidogrel in Unstable Angina to Prevent Recurrent Events ...

European Heart Journal, Sinnaeve, Peter R., Van de Werf, Frans

Date : 01/11/2017 Item size : 164254 bytes